Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer


Cooper R., Brearley E., HÜRMÜZ P., Musunuru H. B. , Richardson C., Swift S., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.290, no.6, pp.1201-1205, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 290 Issue: 6
  • Publication Date: 2014
  • Doi Number: 10.1007/s00404-014-3350-1
  • Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1201-1205
  • Keywords: High-dose-rate brachytherapy, Cervical cancer, Applicator (IU) position, HDR, RECOMMENDATIONS, RADIOTHERAPY, UTERINE, TERMS
  • Hacettepe University Affiliated: Yes

Abstract

Hybrid magnetic resonance imaging/computerized tomography (MRI/CT) planning for high-dose-rate (HDR) brachytherapy in cervical cancer with MR/CT fusion for the first fraction followed by CT for fraction 2 and 3 is used at our center. The aim of this study is to evaluate the position of applicator intrauterine tube (IU) in relation to uterine serosa with each fraction of intracavitary high-dose-rate brachytherapy.